Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Osiris licenses inducing molecule involved in cartilage formation

Dec. 3, 1996

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

Patent issued for method of diagnosing and treating impotence

Dec. 2, 1996

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Avigen reports successful gene therapy with EPO

Nov. 29, 1996

Harvard Scientific seeks to proceed with clinical trials on erectile dysfunction Rx

Nov. 29, 1996

Animal model for testing osteoporotic therapies available for licensing

Nov. 29, 1996

rhBMP-2 cleared for limited clinical trial for spine fusion

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...